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Diabetes Alters Diurnal Rhythm of 
Electroretinogram in db/db Mice
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Diabetic retinopathy (DR†) is the most common complications of diabetes and a leading cause of blindness 
in the United States. The retinal neuronal changes precede the vascular dysfunction observed in DR. The 
electroretinogram (ERG) determines the electrical activity of retinal neural and non-neuronal cells. The 
retinal ERG amplitude is reduced gradually on the progression of DR to a more severe form. Circadian 
rhythms play an important role in the physiological function of the body. While ERG is known to exhibit 
a diurnal rhythm, it is not known whether a progressive increase in the duration of diabetes affects the 
physiological rhythm of retinal ERG. To study this, we determined the ERG rhythm of db/db mice, an 
animal model of type 2 diabetes at 2, 4, and 6 months of diabetes under a regular light-dark cycle and 
constant dark. Our studies demonstrate that the diurnal rhythm of ERG amplitude for retinal a-wave 
and b-wave was altered in diabetes. The implicit time was increased in db/db mice while the oscillatory 
potential was reduced. Moreover, there was a progressive decline in an intrinsic rhythm of ERG upon an 
increase in the duration of diabetes. In conclusion, our studies provide novel insights into the pathogenic 
mechanism of DR by showing an altered circadian rhythm of the ERG.
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INTRODUCTION
The recent report from the Center for Disease Con-
trol and Prevention (CDC) suggests that more than 100 
million Americans are living with diabetes or prediabetes 
[1]. Strikingly, diabetes is the 7th leading cause of death 
in the United States. Diabetes-related eye disease is the 
foremost cause of blindness among adults. The risk of de-
veloping eye disorders among diabetics is 25 times that of 
the general population [2]. Diabetic retinopathy (DR) is 
the most common complications of diabetes with an esti-
mated prevalence of 28.5 percent among US adults with 
diabetes [3]. In addition to DR, long-standing diabetes is 
also associated with an increased risk of diabetic macular 
edema (DME) with a prevalence of 3.8 percent. During 
the first twenty years of diabetes, nearly all patients with 
Type 1 diabetes (T1D) and > 60 percent of patients with 
Type 2 diabetes (T2D) will develop some form of DR [4]. 
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The pathogenesis of DR is complex and multifactorial. 
While the pathologic impact of diabetic milieu is main-
ly observed on retinal vasculature, there is considerable 
evidence that the DR is the disease of the neurovascular 
unit and diabetes-induced changes in retinal neurons and 
glia precede the onset of clinically evident vascular injury 
[5-7].
Circadian rhythm plays an important role in regulat-
ing a variety of biochemical and physiological process-
es of the body such as the sleep-wake cycle, hormone 
release, and feeding behavior. The daily oscillations of 
circadian rhythms are governed by the suprachiasmatic 
nucleus (SCN). The SCN drives the rhythms of other 
peripheral organs including the retina. Interestingly, the 
retinal clock is independent of the SCN and can influence 
the rhythms generated by the SCN [8]. The retinal clock 
regulates photoreceptor survival [9], ganglion cell via-
bility during the aging [10], and critical functions of the 
retina such as phagocytosis, disk shedding, and corneal 
thickness.
The risk of diabetes is increased due to a vari-
ety of circadian rhythm disorders such as irregular 
or poor quality of sleep, circadian misalignment, and 
melatonin dysregulation. Interestingly, experimental 
studies in laboratory animals where the circadian cy-
cle was altered by changing the light exposure pose 
an increased risk of T2D [11] and this observation is 
also reciprocated in shift workers [12] constituting 15 
million Americans [13]. Circadian disruption due to ge-
netic factors also increases the risk of diabetes [14,15]. 
Genetic studies demonstrate that a variant in the re-
ceptor for circadian-regulated hormone melatonin 
(MTNR1B), which is known to be associated with 
increased fasting glucose and T2D is also involved 
with increased duration of endogenous melatonin pro-
duction [16]. On the contrary, diabetes itself leads to 
progressive circadian dysfunction or exacerbates the 
existing circadian rhythm disruption. Diabetic indi-
viduals display a disrupted circadian rhythm of body 
temperature, heart rate, and fasting blood glucose [17]. 
The diabetes-associated gradual alteration in circadian 
rhythm might be associated with compromised retinal 
function. Melatonin levels, an important component of 
a retinal clock, are found to be decreased in diabetes ir-
respective of the stage of DR [18]. The retinal ganglion 
cells in open-angle glaucoma are known to be associated 
with the disrupted circadian rhythm of temperature [18].
The electroretinogram (ERG) is an objective method 
for evaluating a retinal function [19]. The electroretinog-
raphy abnormalities can be observed at an early stage of 
the disease when there are no visible changes in the fun-
dus [20]. In the early stage of DR, i.e. non-proliferative 
DR (NPDR), there is a significant reduction in scotopic 
ERG b-wave amplitude and a decrease in oscillatory po-
tential (OP) [21,22]. There is a further decrease in ERG 
amplitude upon an increase in the severity of the DR from 
mild NPDR to severe NPDR. Several abnormalities are 
observed in ERG parameters with proliferative diabetic 
retinopathy (PDR) such as a decrease in OP or a com-
plete disappearance of OP along with a decrease in ERG 
a-wave and b-wave amplitude [20].
Notably, the retinal ERG also display diurnal rhythm 
both in humans [23,24] and rodents [25], however, how 
diabetes influences this natural rhythm of ERG is not 
studied yet. Moreover, how long-standing diabetes (when 
the retinal vascular defects are evident) influences the 
biological rhythm of ERG is not known. To study this, 
we analyzed ERG rhythm at different time intervals using 
a mouse model of type 2 diabetes, the db/db mice. The 
retinal ERG rhythm was evaluated at 2, 4, and 6 months 
of diabetes. Our studies unravel a progressive decline in 
ERG rhythm with an increase in the duration of diabetes.
MATERIAL AND METHODS
Animal Studies
The C57BL6/J, B6.BKS(D)-Leprdb/J (an animal 
model for T2D; db/db) and Leprdb/+ db/m (heterozygotes; 
db/m) mice were purchased from The Jackson Laborato-
ry. All animal care and experimental procedures were in 
accordance with The Guiding Principles in the Care and 
Use of Animals (NIH). The animals were maintained in a 
12 hr light: 12 hr dark cycle (LD condition). The “lights 
on” time was considered as Zeitgeber time (ZT) 0 and the 
“lights off” time was considered as ZT 12. For studying 
the intrinsic circadian rhythm in the absence of light cues, 
the animals were maintained in complete darkness for 2 
weeks (DD condition) before performing ERG on them. 
Besides the occasional movement of cages for bedding 
change, food & water supply, and examination by the vet-
erinary staff (under red light), the cages were not moved 
from their respective locations. Prior to ERG studies un-
der LD conditions, the animals were dark-adapted over-
night. For both light conditions the ERG was recorded 
at ZT-3, ZT-9, ZT-15, and ZT-21. The mice were anes-
thetized with a mixture of Ketamine and Xylazine. The 
pupils were dilated using 1% tropicamide and 2.5% phen-
ylephrine. The gold loop electrode (LKC Technologies, 
Inc, Gaithersburg, MD, USA) was placed over the cornea 
after the application of Gonak (Hypromellose 2.5% solu-
tion Akorn Inc, Lake Forest, IL), and the scotopic ERG 
recordings were performed using an LKC NGIT-100 re-
cording machine (LKC Technologies, Inc, Gaithersburg, 
MD, USA). The values for a- and b-wave amplitudes and 
implicit times are obtained using an inbuilt analysis tool 
from LKC Technologies.
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Statistics
The data were expressed as Mean ± SEM. The curve 
fitting for raw data was performed using the GraphPad 
Prism 8 software (GraphPad Software, La Jolla, CA) 
as described [26]. The amplitude and phase values ob-
tained from the curve fitting were further analyzed using 
a multifactor ANOVA. Circadian rhythmicity for ERG in 
C57BL6/J mice was determined using the equation (Am-
plitude*cos (ZT/24*(2*pi)+phase)+mesor) in an R pro-
gram (version 3.5.1)
In addition, for studies involving diabetic mice, we 
evaluated the difference in circadian parameters in mice 
with the three factors disease/genotype (db/db vs db/m); 
diabetes duration (2 vs 4 vs 6 months) and light condition 
(LD vs DD), the animals were subgrouped accordingly. 
The statistical significance of circadian oscillation for 
each subgroup was first evaluated by a zero-amplitude 
test. To evaluate the circadian oscillation, a linear model 
that can be transferred to a single cosine function was 
used and a zero-amplitude test was performed using this 
model. For the subgroups that demonstrated circadian os-
cillation, we further tested whether there is any difference 
in circadian parameters (mesor difference; phase shift; 
amplitude difference) by performing a log-likelihood 
ratio test. If there was any significant difference in cir-
cadian parameters, we used a permutation test between 
any paired subgroups to test which circadian parameters 
were different. A p value of less than 0.05 was considered 
as statistically significant using an R program (version 
3.5.1).
RESULTS
The Diurnal Rhythm of ERG in Wild-Type Mice
To study whether ERG exhibits a diurnal rhythm in 
C57BL6/J mice, we performed ERG assessments at 6 hr 
intervals. The amplitude of an ERG b-wave was highest in 
between ZT-9 and ZT-15 at all the light intensities tested. 
The zero amplitude test revealed that the ERG response 
exhibits a diurnal rhythm for ERG b-wave (Figure 1a) at 
0.025 cd.s/m2 and 0.25 cd.s/m2. The ERG a-wave showed 
a peak response between ZT-9 and ZT-15 and a circadian 
rhythm (Figure 1b) at the lower light intensities. The im-
plicit time exhibited a diurnal rhythm at 0.025 cd.s/m2 for 
b-wave, however, the other two intensities (0.25 and 2.5 
cd.s/m2) did not show a diurnal rhythm, (Figure 1c, d). 
The implicit time for a-wave exhibited a diurnal rhythm 
at all the light intensities. The oscillatory potential did not 
show a diurnal rhythm at all the light intensities, with a 
peak at ZT-9 (Figure 1e).
Diabetes Alters ERG Rhythm in db/db Mice Under 
Regular Light and Dark Conditions
We assessed the ERG rhythm of db/m (controls) and 
db/db mice (type 2 diabetes) at time points similar to the 
C57BL6/J mice under 12 hr light and 12 hr dark condi-
tions. The ERG recordings were conducted at 2, 4, and 6 
months of diabetes.
At two months’ time point, the peak of ERG b-wave 
was observed between ZT-3 and ZT-9 while at the lowest 
point between ZT-15 and ZT-21 in db/m mice. For db/db 
mice, the peak response was at ZT-15 for 0.025 and 2.5 
cd.s/m2 light intensities. However, for 0.25 cd.s/m2 light 
intensity, the peak was in between ZT-9 and ZT-15. The 
zero amplitude test revealed a diurnal rhythm for all light 
intensities for db/m mice. Overall, there was an increase 
in ERG b-wave amplitude for db/db mice at higher inten-
sities, except for the lower intensity of light, 0.025 cd.s/
m2. However, there was no significant diurnal rhythm of 
ERG b-wave for db/db mice at all the intensities. The 
b-wave implicit time exhibited a diurnal rhythm for db/m 
mice at 2.5 cd.s/m2 and db/db mice for 0.025, 0.25 cd.s/
m2. While the oscillatory potential exhibited a diurnal 
rhythm only at a higher intensity for db/m mice, none of 
the other groups demonstrated a diurnal rhythm for oscil-
latory potential. The a-wave demonstrated a peak at ZT-9 
for 0.025 and 0.25 cd.s/m2 intensity in db/m mice; how-
ever, the peak for 2.5 cd.s/m2 was in between ZT-3 and 
ZT-9. In db/db mice, the peak for a-wave was at ZT-15 for 
0.025 and 0.25 cd.s/m2, and at ZT-9 for 2.5 cd.s/m2 light 
intensity. The amplitude of a-wave was higher in db/db 
mice when compared to db/m mice. The a-wave demon-
strated a diurnal rhythm for 0.25 cd.s/m2 and 2.5 cd.s/m2, 
however, diabetic mice did not demonstrate a circadian 
rhythm at all the intensities that were tested. The implicit 
time for a-wave showed a diurnal rhythm for db/m mice 
at 0. 25 cd.s/m2 and 2.5 cd.s/m2, however, for db/db mice 
lacked diurnal rhythm at all the intensities. (Figure 2).
At 4 months, there was a shift in ERG peak to ZT-
21 for intensities 0.025 and 0.25 cd.s/m2, however, for 
the light intensity of 2.5, the peak was similar to a two-
month time point for db/m mice. In db/db mice, the peak 
response was earlier at ZT-9 in comparison to a 2-month 
time point at 0.025 cd.s/m2 intensity. Overall, there was 
an increase in the amplitude for b-wave in db/db mice as 
compared to db/m mice. By 4 months, both groups lost 
a diurnal rhythm of ERG response. The implicit time for 
b-wave showed a diurnal rhythm at all intensities for db/
db mice, however, this rhythm was only observed at 2.5 
cd.s/m2 for db/m mice. The oscillatory potentials demon-
strated a diurnal rhythm in all groups and at all intensities 
except 2.5 cd.s/m2 for db/m mice. There was a shift in 
peak response for a-wave for both db/m and db/db mice 
at 4 months when compared to a two-month time point. 
The peak response for 0.025 cd.s/m2 shifted earlier to 
ZT-9, while for other two intensities the peak response 
was moved in between ZT-15 and ZT-21. The db/db mice 
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plicit time for b-wave exhibited a diurnal rhythm at 0.25 
cd.s/m2 for db/m mice and 2.5 cd.s/m2 intensity for db/db 
mice. The oscillatory potential showed a diurnal rhythm 
only at 0.025 cd.s/m2 for db/m mice. The a-wave peaked 
in between ZT-15 and ZT-21 for lower intensities in db/m 
mice, while at the higher intensity the peak response was 
observed at ZT-3. The db/db mice did not demonstrate 
an obvious peak, the highest response was observed be-
tween ZT-9 and ZT-15. There was an overall decrease in 
ERG a-wave amplitude and loss of diurnal rhythmicity. 
The implicit time of a-wave did not demonstrate a diurnal 
rhythm for both db/m and db/db mice at all the light in-
tensities tested (Figure 2).
followed a similar pattern. There was an overall increase 
in a-wave amplitude in db/db mice. None of the groups 
exhibited a diurnal rhythm for ERG a-wave. The a-wave 
implicit time did show a diurnal rhythm at higher intensi-
ties for both db/m and db/db mice and at the lowest inten-
sity of db/m mice (Figure 2).
As diabetes progressed to 6 months and db/m mice 
aged, there was a progressive decline in ERG amplitude 
compared to 2- and 4-months’ time points. The peak re-
sponse of b-wave in db/m mice was at ZT-9 for 0.025, 
0.25 cd.s/m2 intensity, while at ZT-21 for at 2.5 cd.s/m2. 
The ERG b-wave peaked at ZT-3 and ZT-15 for 0.25 and 
2.5 cd.s/m2 light intensity respectively in db/db mice. 
The ERG amplitude was lower for db/db mice at lower 
intensities, however, was increased at 2.5 cd.s/m2 when 
compared to db/m mice. There was no diurnal rhythm 
for both groups at all intensities for the b-wave. The im-
Figure 1. Diurnal ERG rhythm in C57BL6/J mice. The ERG recordings were performed at 6 hr time intervals. Each 
time point for ERG assessment is expressed as Zeitgeber (ZT) time, which corresponds to 12 hr light-dark cycles 
with lights being turned on at ZT-0 and off at ZT-12. A scatter plot with a curve fitting for a raw ERG data of (a) b-wave 
and (b) a-wave, implicit time of (c) ERG b-wave (d) a-wave and (e) an oscillatory potential for ERG , n=5 *p<0.05, ** 
p<0.01,*** p<0.001.
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amplitude test demonstrated a circadian rhythm only at 
0.025 cd.s/m2 intensity for db/m mice, none of the oth-
er groups demonstrated a diurnal rhythm. There was an 
overall decrease in amplitude of ERG b-wave in db/db 
mice when compared to db/m mice. The implicit time 
of ERG b-wave exhibited a circadian rhythm at 2.5 cd.s/
m2, for db/db mice, however, none of the other groups 
demonstrated a circadian rhythm. The oscillatory poten-
tials showed a circadian rhythm only at 2.5 cd.s/m2 for 
Intrinsic Circadian Rhythm of ERG is Decreased in 
Diabetes
Next, we tested the intrinsic rhythm of retinal ERG 
in mice with different duration of diabetes. The animals 
were maintained in constant dark for two weeks to nullify 
the effect of external light stimuli on the biological clock.
At 2 months’ time point, the b-wave exhibited a peak 
response at ZT-9 in db/m mice, however, with diabetes, 
this peak shifted in between ZT-15 and ZT-21. The zero 
Figure 2. ERG rhythm in db/db mice under regular light-dark conditions. ERG recordings were performed at 2, 4 
and 6 months of diabetes at different time points. Scatter plot showing ERG b-wave amplitude, implicit time, oscillato-
ry potential, and ERG a-wave amplitude and implicit time. Each data point represents average value; the connecting 
line corresponds to fitted curve line for the respective group (2-months db/m n=5, db/db n=5; 4-months db/m n=5, db/
db n=7; 6-months db/m n=4, db/db n=5) , *p<0.05, ** p<0.01, *** p<0.001.
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time point. The peak time of amplitude was shifted in 
between ZT-15 and ZT-21 for db/m animals. The db/
db mice showed an overall decrease in ERG amplitude. 
None of the groups demonstrated circadian rhythmicity. 
The b-wave implicit time showed an overall increase in 
db/db mice in comparison to the db/m animals without the 
presence of circadian rhythm. The oscillatory potential 
did not show a circadian rhythm at all the light intensities 
and was lower for db/db animals. The a-wave amplitude 
db/m mice, and was lower for db/db mice and did not ex-
hibit any rhythm. The peak of a-wave amplitude was ob-
served between ZT-15 and ZT-21 for db/db mice. There 
was an overall decrease in the amplitude of a-wave in db/
db mice when compared to db/m animals. The a-wave 
implicit time did not show a circadian rhythm in both 
db/m and db/db animals (Figure 3).
At 4 months’ time point there was a gradual decrease 
in ERG b-wave amplitude as compared to two months’ 
Figure 3. An intrinsic rhythm of ERG is decreased in db/db mice. The animals were maintained in the constant 
dark to nullify the effect of extrinsic light stimuli and the ERG recordings were performed at different time intervals 
at 2, 4, and 6 months of duration of diabetes. Scatter plot showing ERG amplitude and implicit time for b-wave and 
a-wave, and an oscillatory potential for ERG. Each data point showing an average value, the connecting line corre-
sponds to fitted curve, (2-months db/m n=9, db/db n=9; 4-months db/m n=5, db/db n=7; 6-months db/m n=5, db/db 
n=5), *p<0.05, **p<0.01, *** p<0.001.
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db/db mice, a decrease in ERG amplitude with a loss of 
circadian rhythmicity was observed at all intensities. The 
b-wave implicit time and oscillatory potentials of both 
db/m and db/db mice lacked circadian rhythmicity. The 
a-wave exhibited a peak response in between ZT-9 and 
ZT-15 for db/m mice at lower light intensities, which was 
shifted to in between ZT-15 and ZT-21 as the light inten-
sity is increased to 2.5 cd.s/m2. The a-wave at 0.025 cd.s/
m2 showed a circadian rhythm. The peak increase in ERG 
amplitude for db/db mice was observed between ZT-15 
showed a peak response at ZT-9 in db/m mice for 0.025 
and 0.25 cd.s/m2. In db/db mice the peak of ERG a-wave 
was observed in between ZT15 and ZT-21. There was no 
circadian rhythm for ERG a-wave. The a-wave implicit 
time demonstrated an increase in db/db mice with a circa-
dian rhythm at 0.25 cd.s/m2 (Figure 3).
As diabetes progressed to 6 months a further decrease 
in ERG b-wave amplitude was observed as compared to 2 
and 4 months’ time points. The peak of ERG b-wave was 
observed in between ZT-15 and ZT-21 for db/m mice. In 
Figure 4. Circadian amplitude and phase of ERG parameters. Bar chart showing circadian amplitude and phase 
for b-wave, a-wave amplitude, oscillatory potential and implicit times. (LD condition: 2-months db/m n=5, db/db n=5; 
4-months db/m n=5, db/db n=7; 6-months db/m n=4, db/db n=5; DD conditions: 2-months db/m n=9, db/db n=9; 
4-months db/m n=5, db/db n=7; 6-months db/m n=5, db/db n=5).
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DISCUSSION
Our study demonstrates that C57BL6/J mice exhibit 
a diurnal rhythm of scotopic ERG, for both a- and b-wave 
and the implicit time. Overall, the pattern of ERG wave 
was altered in db/db mice, there was a complete loss of 
diurnal rhythm from 2 months of diabetes for both ERG 
b- and a-wave in db/db mice. Increase in acellular cap-
illaries is a pathologic hallmark of DR. In db/db mice, 
the acellular capillaries are evident after 4 months of dia-
betes [22,27]. The ERG abnormalities are also prevalent 
between 4 and 6 months of diabetes [28]. Therefore, we 
predict that in our studies the changes in ERG parame-
ters, such as ERG amplitude and OPs, will correlate with 
the numbers of acellular capillary numbers. However, it 
was not studied in this manuscript.
One of the key findings of our study using C57BL6/J 
mice was defining the time points for a peak and trough 
response. Overall, the greatest response of ERG ampli-
tude was observed between ZT-9 and ZT-15, and at the 
lowest level at ZT-21. While the previous studies per-
formed in the mouse retina, demonstrated that the ERG 
b-wave amplitude is highest during the middle of the 
day (i.e. resting phase for nocturnal animals) and at the 
lowest at midnight (activity phase) [25], our study for the 
first time performed ERG assessments at four different 
time intervals to define the time-point for a peak ERG 
response. This observation warrants that timing of ERG 
assessment is critical for interpretation of the data and 
maintaining consistency of timing is critical for ERG 
studies. ERG studies on humans exhibit a similar re-
sponse to some extent, where there is an evident increase 
(20 to 40 percent) in ERG during night time as compared 
to the daytime [23,29], and an increase in ERG implicit 
time earlier in the morning [30]. However, some stud-
ies observed conflicting findings where ERG amplitude 
was at the highest at 12 PM (activity phase) and lowest 
at 6 AM (resting phase) in humans [24]. Previous studies 
demonstrate that only photopic ERG is under circadian 
control, whereas a circadian clock does not regulate the 
scotopic ERG [31]. Moreover, deficiency of melatonin in 
C57BL6/J mice [32] might be attributed to lack of clock 
regulation of scotopic ERG [33]. While the above aspects 
were beyond the scope of this study, our study highlight-
ed the presence of diurnal rhythm of ERG amplitude in 
C57BL6/J mice. It is noteworthy that retinal rhythms are 
predominantly mediated by local oscillations, and SCN 
clock cannot compensate for the loss of local retinal os-
cillators. Storch et al. further reinforced the concept of 
the local retinal clock by demonstrating that conditional 
deletion of a clock gene Bmal1 in SCN does not affect 
ERG rhythm [8].
We demonstrate that ERG b-wave was altered in 
diabetic retinas. While the diurnal rhythm of ERG was 
and ZT-21. The implicit time for ERG a-wave did not 
show a circadian rhythm at any of the light intensities in 
db/m and db/db mice. (Figure 3).
In order to further determine an effect of genotype 
(db/m vs db/db), light conditions (LD vs DD) and du-
ration of diabetes, we determined amplitude and phase 
for each of the parameters tested from the curve fitting 
data obtained from GraphPad Prism. For the b-wave the 
circadian phase for the duration of diabetes and light con-
ditions differed significantly; there was also a difference 
between diabetes duration and genotype as well as dia-
betes duration and light conditions. The phase of b-wave 
implicit time also differed significantly at the above pa-
rameters as well as all three conditions (Appendix A Ta-
ble 1). There was no statistical difference for circadian 
amplitude for b-wave. Overall, there was a trend towards 
an increase in circadian phase at 2, 6 months, however 
not for 4 months’ time point (Figure 4). While the a-wave 
circadian amplitude did not differ significantly across the 
different comparisons, the circadian phase differed sig-
nificantly for the duration of diabetes as well as in differ-
ent comparisons between the groups. The a-wave implicit 
time for circadian phase differed significantly across all 
the statistical comparisons (Appendix A Table 1). There 
was a general trend towards a decrease in circadian am-
plitude for a-wave, however the data was inconclusive as 
some of the frequencies (0.025 cd.s/m2 and 0.25 cd.s/m2 
at 2 months and 0.25 cd.s/m2 at 4 months) did show some 
increase in circadian amplitude for a-wave. There was an 
increase in circadian phase at 4 months under DD condi-
tion and at 6 months for both LD and DD conditions for 
db/db mice (Figure 4). The oscillatory potential for circa-
dian amplitude for the duration of diabetes across lighting 
conditions did differ significantly as well as there was a 
significant difference in circadian phase in all the statis-
tical comparisons (Appendix A Table 1). By 6 months of 
diabetes, there was a decrease in circadian amplitude of 
oscillatory potential for db/db mice under both LD and 
DD conditions, the changes in a circadian phase were in-
conclusive (Figure 4).
To further understand the changes in a circadian 
rhythm across the genotype, duration of diabetes, light-
ing conditions and individual intensities, we developed 
a robust mathematical model in R and performed a ze-
ro-amplitude test followed by a log-likelihood test for an 
individual subgroup that passed the zero-amplitude test. 
The significance of the difference in circadian parameters 
(mesor; amplitude; phase) was evaluated by 500 times 
model residuals resampling and the p-value was obtained 
from the empirical distribution. Out of all the compari-
sons, only the a-wave implicit time differed significant-
ly for 2.5 cd.s/m2 between 2 and 4 months, (Appendix A 
Table 2).
Di et al.: Diabetes affects electroretinogram rhythm 163
circadian rhythm of an ERG.
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Appendix A Table 1
Source of Variation F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value
Diabetes duration F (2, 103) = 0.8919 P=0.4130 F (2, 130) = 0.3856 P=0.6808 F (2, 115) = 2.781 P=0.0662 F (2, 103) = 48.28 P<0.0001 F (2, 105) = 53.02 P<0.0001 F (2, 115) = 27.83 P<0.0001
Light condition F (1, 103) = 0.06591 P=0.7979 F (1, 130) = 0.000 P>0.9999 F (1, 115) = 0.2314 P=0.6314 F (1, 103) = 51.82 P<0.0001 F (1, 105) = 18.95 P<0.0001 F (1, 115) = 36.73 P<0.0001
Genotype F (1, 103) = 0.07411 P=0.7860 F (1, 130) = 0.9293 P=0.3368 F (1, 115) = 0.2689 P=0.6051 F (1, 103) = 0.0264 P=0.8712 F (1, 105) = 0.0205 P=0.8863 F (1, 115) = 0.2290 P=0.6332
Diabetes duration x Light condition F (2, 103) = 1.070 P=0.3467 F (2, 130) = 0.000 P>0.9999 F (2, 115) = 0.7016 P=0.4979 F (2, 103) = 3.189 P=0.0453 F (2, 105) = 9.395 P=0.0002 F (2, 115) = 1.940 P=0.1484
Diabetes duration x Genotype F (2, 103) = 0.2046 P=0.8153 F (2, 130) = 3.846 P=0.0238 F (2, 115) = 0.5671 P=0.5687 F (2, 103) = 19.29 P<0.0001 F (2, 105) = 30.09 P<0.0001 F (2, 115) = 3.410 P=0.0364
Light condition x Genotype F (1, 103) = 0.4115 P=0.5226 F (1, 130) = 0.000 P>0.9999 F (1, 115) = 0.8793 P=0.3504 F (1, 103) = 22.23 P<0.0001 F (1, 105) = 5.844 P=0.0174 F (1, 115) = 0.2772 P=0.5995
Diabetes duration x Light condition x Genotype F (2, 103) = 1.387 P=0.2545 F (2, 130) = 0.000 P>0.9999 F (2, 115) = 1.223 P=0.2983 F (2, 103) = 1.324 P=0.2706 F (2, 105) = 3.608 P=0.0305 F (2, 115) = 5.018 P=0.0081
Source of Variation F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value
Diabetes duration F (2, 104) = 1.395 P=0.2525 F (2, 116) = 2.347 P=0.1002 F (2, 104) = 317.1 P<0.0001 F (2, 116) = 20.56 P<0.0001
Light condition F (1, 104) = 0.1081 P=0.7430 F (1, 116) = 0.5071 P=0.4778 F (1, 104) = 2.181 P=0.1428 F (1, 116) = 99.69 P<0.0001
Genotype F (1, 104) = 0.1462 P=0.7029 F (1, 116) = 0.3758 P=0.5411 F (1, 104) = 48.78 P<0.0001 F (1, 116) = 123.1 P<0.0001
Diabetes duration x Light condition F (2, 104) = 0.7621 P=0.4693 F (2, 116) = 1.018 P=0.3647 F (2, 104) = 22.63 P<0.0001 F (2, 116) = 31.03 P<0.0001
Diabetes duration x Genotype F (2, 104) = 0.1551 P=0.8566 F (2, 116) = 1.316 P=0.2721 F (2, 104) = 80.23 P<0.0001 F (2, 116) = 29.44 P<0.0001
Light condition x Genotype F (1, 104) = 0.007785 P=0.9299 F (1, 116) = 1.623 P=0.2052 F (1, 104) = 107.2 P<0.0001 F (1, 116) = 10.78 P=0.0014
Diabetes duration x Light condition x Genotype F (2, 104) = 1.457 P=0.2376 F (2, 116) = 2.047 P=0.1337 F (2, 104) = 0.7261 P=0.4862 F (2, 116) = 57.34 P<0.0001
Source of Variation F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value
Diabetes duration F (2, 106) = 1.405 P=0.2499 F (2, 122) = 1.840 P=0.1632 F (2, 110) = 0.6375 P=0.5306 F (2, 106) = 22.32 P<0.0001 F (2, 122) = 0.4893 P=0.6143 F (2, 110) = 22.87 P<0.0001
Light condition F (1, 106) = 0.1018 P=0.7503 F (1, 122) = 10.35 P=0.0017 F (1, 110) = 0.3331 P=0.5650 F (1, 106) = 39.75 P<0.0001 F (1, 122) = 0.1401 P=0.7088 F (1, 110) = 0.0172 P=0.8958
Genotype F (1, 106) = 0.4155 P=0.5206 F (1, 122) = 2.164 P=0.1438 F (1, 110) = 0.3871 P=0.5351 F (1, 106) = 76.32 P<0.0001 F (1, 122) = 0.5455 P=0.4616 F (1, 110) = 0.5347 P=0.4662
Diabetes duration x Light condition F (2, 106) = 5.505 P=0.0053 F (2, 122) = 2.070 P=0.1306 F (2, 110) = 0.3463 P=0.7081 F (2, 106) = 1.220 P=0.2994 F (2, 122) = 0.5318 P=0.5889 F (2, 110) = 35.87 P<0.0001
Diabetes duration x Genotype F (2, 106) = 1.168 P=0.3150 F (2, 122) = 0.9081 P=0.4060 F (2, 110) = 1.143 P=0.3225 F (2, 106) = 13.29 P<0.0001 F (2, 122) = 0.8461 P=0.4316 F (2, 110) = 20.75 P<0.0001
Light condition x Genotype F (1, 106) = 0.4823 P=0.4889 F (1, 122) = 0.006925 P=0.9338 F (1, 110) = 0.2316 P=0.6313 F (1, 106) = 3.468 P=0.0653 F (1, 122) = 3.924 P=0.0498 F (1, 110) = 14.83 P=0.0002
Diabetes duration x Light condition x Genotype F (2, 106) = 2.045 P=0.1344 F (2, 122) = 1.478 P=0.2321 F (2, 110) = 0.6245 P=0.5374 F (2, 106) = 12.47 P<0.0001 F (2, 122) = 2.885 P=0.0597 F (2, 110) = 8.709 P=0.0003
Source of Variation F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value
Diabetes duration F (2, 116) = 1.291 P=0.2790 F (2, 112) = 0.08655 P=0.9171 F (2, 108) = 81.56 P<0.0001 F (2, 114) = 9.529 P=0.0001
Light condition F (1, 116) = 1.413 P=0.2370 F (1, 112) = 0.00021 P=0.9884 F (1, 108) = 9.970 P=0.0021 F (1, 114) = 155.0 P<0.0001
Genotype F (1, 116) = 0.07126 P=0.7900 F (1, 112) = 0.5778 P=0.4488 F (1, 108) = 114.8 P<0.0001 F (1, 114) = 120.7 P<0.0001
Diabetes duration x Light condition F (2, 116) = 0.01592 P=0.9842 F (2, 112) = 5.938 P=0.0035 F (2, 108) = 46.21 P<0.0001 F (2, 114) = 1.068 P=0.3472
Diabetes duration x Genotype F (2, 116) = 1.843 P=0.1630 F (2, 112) = 1.367 P=0.2590 F (2, 108) = 18.79 P<0.0001 F (2, 114) = 6.632 P=0.0019
Light condition x Genotype F (1, 116) = 0.1636 P=0.6866 F (1, 112) = 0.4475 P=0.5049 F (1, 108) = 2.550 P=0.1132 F (1, 114) = 111.2 P<0.0001
Diabetes duration x Light condition x Genotype F (2, 116) = 2.054 P=0.1329 F (2, 112) = 0.8775 P=0.4186 F (2, 108) = 22.39 P<0.0001 F (2, 114) = 8.187 P=0.0005
Source of Variation F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value F (DFn, DFd) P value
Diabetes duration F (2, 105) = 1.277 P=0.2831 F (2, 115) = 2.042 P=0.1344 F (2, 110) = 0.7743 P=0.4635 F (2, 107) = 8.333 P=0.0004 F (2, 122) = 28.85 P<0.0001 F (2, 129) = 40.74 P<0.0001
Light condition F (1, 105) = 2.675 P=0.1049 F (1, 115) = 0.01964 P=0.8888 F (1, 110) = 0.2753 P=0.6009 F (1, 107) = 20.40 P<0.0001 F (1, 122) = 27.66 P<0.0001 F (1, 129) = 28.39 P<0.0001
Genotype F (1, 105) = 0.01595 P=0.8997 F (1, 115) = 0.09851 P=0.7542 F (1, 110) = 0.00444 P=0.9470 F (1, 107) = 3.976 P=0.0487 F (1, 122) = 6.119 P=0.0148 F (1, 129) = 214.3 P<0.0001
Diabetes duration x Light condition F (2, 105) = 3.468 P=0.0348 F (2, 115) = 4.155 P=0.0181 F (2, 110) = 0.9225 P=0.4006 F (2, 107) = 59.42 P<0.0001 F (2, 122) = 12.63 P<0.0001 F (2, 129) = 2.351 P=0.0993
Diabetes duration x Genotype F (2, 105) = 1.909 P=0.1534 F (2, 115) = 0.8899 P=0.4135 F (2, 110) = 1.143 P=0.3226 F (2, 107) = 1.863 P=0.1602 F (2, 122) = 22.96 P<0.0001 F (2, 129) = 20.28 P<0.0001
Light condition x Genotype F (1, 105) = 0.3200 P=0.5728 F (1, 115) = 0.3084 P=0.5797 F (1, 110) = 0.1214 P=0.7282 F (1, 107) = 142.7 P<0.0001 F (1, 122) = 15.82 P=0.0001 F (1, 129) = 177.0 P<0.0001
Diabetes duration x Light condition x Genotype F (2, 105) = 0.6871 P=0.5053 F (2, 115) = 0.03918 P=0.9616 F (2, 110) = 0.9309 P=0.3973 F (2, 107) = 54.96 P<0.0001 F (2, 122) = 11.20 P<0.0001 F (2, 129) = 86.40 P<0.0001
a-wave amplitude
a-wave implicit time 
Oscillatory potential
b-wave amplitude 
b-wave implicit time 
Circadian  Amplitude Circadian  Phase
0.025 cd.s/m2 0.25  cd.s/m2 2.5  cd.s/m2 0.025  cd.s/m2 0.25  cd.s/m2 2.5  cd.s/m2
Circadian  Amplitude Circadian  Phase
0.025 cd.s/m2
Circadian  Amplitude Circadian  Phase
0.025 cd.s/m2 0.25  cd.s/m2 2.5  cd.s/m2 0.025  cd.s/m2 0.25  cd.s/m2 2.5  cd.s/m2
0.25  cd.s/m2 2.5  cd.s/m2 0.025  cd.s/m2 0.25  cd.s/m2 2.5  cd.s/m2
Circadian  Amplitude Circadian  Phase
0.025 cd.s/m2 0.25  cd.s/m2 2.5  cd.s/m2 0.025  cd.s/m2 0.25  cd.s/m2 2.5  cd.s/m2
0.025 cd.s/m2 0.25  cd.s/m2 2.5  cd.s/m2
Circadian  Amplitude Circadian  Phase
0.025  cd.s/m2 0.25  cd.s/m2 2.5  cd.s/m2
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P value difference P value difference P value difference
0.168 -15.38205 0.136 3.4967 0.48927 -6.64564db/m_0.025 cd·s/m2_2months_LD vs. db/db_0.025 cd·s/m2_2months_DD














P value difference P value difference P value difference
0.762 0.31143 0.272 -0.64412 0 4.83522
0.11 -5.64191 0.308 0.44967 0 -15.77774
0.33 3.13999 0.432 -0.39617 0.00337 -7.0884
0.28 1.26434 0.48 -0.35188 0.74649 0.4595
db/db_0.25 cd·s/m2_2months_LD vs. db/db_0.25 cd·s/m2_4months_LD
db/db_2.5 cd·s/m2_4months_LD vs. db/db_2.5 cd·s/m2_6months_DD
Amplitude Phase Group mean
Comparsion groups
db/m_2.5 cd·s/m2_4months_LD vs. db/db_2.5 cd·s/m2_4months_LD









P value difference P value difference P value difference
0.736 -1.31091 0.108 -0.855 0.52431 -0.13927db/db_0.025 cd·s/m2_2months_DD vs. db/db_0.025 cd·s/m2_4months_DD
Amplitude Phase Group mean
Comparsion groups










P value difference P value difference P value difference
0.008 -2.58087 0.762 0.12825 0.00001 -2.97329
0.102 -1.685 0.224 0.47793 0.00001 3.49772
0.476 0.64089 0.54 0.48204 0.0001 2.54497
0.824 -0.25499 0.846 0.14235 0 -3.92604
db/m_2.5 cd·s/m2_4months_LD vs. db/db_2.5 cd·s/m2_4months_LD
db/db_2.5 cd·s/m2_2months_LD vs. db/db_2.5 cd·s/m2_4months_LD
Amplitude Phase Group mean
db/m_2.5 cd·s/m2_2months_LD vs. db/m_2.5 cd·s/m2_4months_LD
Comparsion groups











P value difference P value difference P value difference
0.962 -2.71738 0.186 -0.92438 0.10716 50.2001
0.288 24.20915 0.674 -0.22768 0.00023 -65.304
0.37 27.55133 0.792 0.1032 0.00016 -89.08891
0.904 -2.60838 0.922 -0.06239 0 -87.07567db/m_0.025 cd·s/m2_4months_LD vs. db/m_0.025 cd·s/m2_6months_LD
Group mean
Comparsion groups
db/m_2.5 cd·s/m2_2months_DD vs. db/m_2.5 cd·s/m2_2months_LD
db/m_0.025 cd·s/m2_4months_LD vs. db/m_2.5 cd·s/m2_2months_LD
db/m_0.25 cd·s/m2_4months_LD vs. db/db_0.25 cd·s/m2_4months_LD
Amplitude Phase
